89 related articles for article (PubMed ID: 28245390)
1. [Abnormal Expression and Clinical Significance of B Lymphocyte Stimulating Factor in B Cell-derived Malignant Hematologic Diseases].
Han XL; Zhang XY; Li JD; Wang WL; Yang C
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):138-141. PubMed ID: 28245390
[TBL] [Abstract][Full Text] [Related]
2. Targeting B-lymphocyte stimulator/B-cell activating factor and a proliferation-inducing ligand in hematologic malignancies.
Shivakumar L; Ansell S
Clin Lymphoma Myeloma; 2006 Sep; 7(2):106-8. PubMed ID: 17026820
[TBL] [Abstract][Full Text] [Related]
3. BLyS and BLyS receptor expression in non-Hodgkin's lymphoma.
Briones J; Timmerman JM; Hilbert DM; Levy R
Exp Hematol; 2002 Feb; 30(2):135-41. PubMed ID: 11823048
[TBL] [Abstract][Full Text] [Related]
4. The B lymphocyte stimulator receptor-ligand system in hepatitis C virus-induced B cell clonal disorders.
Landau DA; Rosenzwajg M; Saadoun D; Klatzmann D; Cacoub P
Ann Rheum Dis; 2009 Mar; 68(3):337-44. PubMed ID: 18434450
[TBL] [Abstract][Full Text] [Related]
5. Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome.
Novak AJ; Grote DM; Stenson M; Ziesmer SC; Witzig TE; Habermann TM; Harder B; Ristow KM; Bram RJ; Jelinek DF; Gross JA; Ansell SM
Blood; 2004 Oct; 104(8):2247-53. PubMed ID: 15251985
[TBL] [Abstract][Full Text] [Related]
6. The rGel/BLyS fusion toxin inhibits STAT3 signaling via down-regulation of interleukin-6 receptor in diffuse large B-cell lymphoma.
Lyu MA; Sung B; Cheung LH; Marks JW; Aggarwal BB; Aguiar RC; Rosenblum MG
Biochem Pharmacol; 2010 Nov; 80(9):1335-42. PubMed ID: 20654581
[TBL] [Abstract][Full Text] [Related]
7. [Clinical Analysis of Adoptive Immunotherapy after Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation in B Lymphocyte Malignant Lymphoma].
Wang CB; Pan YZ; Xi R; Xu SF; Zhang Q; Chen Y; Zhou JM; Wu T; Bai H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Dec; 24(6):1748-1753. PubMed ID: 28024488
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus-associated B-cell proliferation--the role of serum B lymphocyte stimulator (BLyS/BAFF).
Sène D; Limal N; Ghillani-Dalbin P; Saadoun D; Piette JC; Cacoub P
Rheumatology (Oxford); 2007 Jan; 46(1):65-9. PubMed ID: 16782735
[TBL] [Abstract][Full Text] [Related]
9. B-Lymphocyte stimulator: a new biomarker for multiple myeloma.
Jiang P; Yueguo W; Huiming H; Hongxiang Y; Mei W; Ju S
Eur J Haematol; 2009 Apr; 82(4):267-76. PubMed ID: 19187273
[TBL] [Abstract][Full Text] [Related]
10. Comparative study on the level of B lymphocyte stimulator (BlyS) and frequency of lymphocytes between sero-negative and sero-positive rheumatoid arthritis patients.
Geng Y; Zhang ZL
Int J Rheum Dis; 2012 Oct; 15(5):478-85. PubMed ID: 23083038
[TBL] [Abstract][Full Text] [Related]
11. The effect of BLyS on the activity of peripheral B lymphocytes mediated by BLyS receptors in patients with systemic lupus erythematosus.
Cheng Y; Yan S; Zhao W; Huang Q; Lian L; Wei W
Scand J Clin Lab Invest; 2013 Mar; 73(2):141-7. PubMed ID: 23336587
[TBL] [Abstract][Full Text] [Related]
12. Human B lymphocyte malignancies: exploitation of BLyS and APRIL and their receptors.
Jelinek DF; Darce JR
Curr Dir Autoimmun; 2005; 8():266-88. PubMed ID: 15564725
[TBL] [Abstract][Full Text] [Related]
13. [Ki-67 proliferative index in non-Hodgkin's lymphoma and its clinical significance].
Li J; Hu R; Liao AJ; Shi HY; Yan W; Liu ZG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):935-9. PubMed ID: 21867618
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of the efficacy of CCCG-97 and BFM-90 protocols in the treatment for children with mature B-cell non-Hodgkin's lymphoma].
Meng JH; Gao YJ; Lu FJ; Zhai XW; Wang HS; Li J
Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):222-7. PubMed ID: 22780979
[TBL] [Abstract][Full Text] [Related]
15. Hematologic Malignancies Discovered on Investigation of Breast Abnormalities.
Alsadi A; Lin D; Alnajar H; Brickman A; Martyn C; Gattuso P
South Med J; 2017 Oct; 110(10):614-620. PubMed ID: 28973700
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of PD-1 and TIM-3 on CD3+ T cells from diffuse large B-cell lymphoma.
Zhang L; Du H; Xiao TW; Liu JZ; Liu GZ; Wang JX; Li GY; Wang LX
Biomed Pharmacother; 2015 Oct; 75():83-7. PubMed ID: 26463635
[TBL] [Abstract][Full Text] [Related]
17. Expression and effects of B-lymphocyte stimulator and its receptors in T cell-mediated autoimmune arthritis.
Chang Y; Sun X; Jia X; Xu S; Wei F; Yang X; Wei W
Int Immunopharmacol; 2015 Feb; 24(2):451-457. PubMed ID: 25598291
[TBL] [Abstract][Full Text] [Related]
18. [Comparing CHOP, CHOP+HD-MTX,and BFM-90 regimens in the survival rate of children and adolescents with B cell non-Hodgkin's lymphoma].
Sun XF; Su YS; Liu DG; Jiang WQ; He YJ; Lin TY; Huang HQ; Zhang L; Xia ZJ; Li YH; Zhou ZM; Chen XQ; Xia Y; Zhen ZJ; Guan ZZ
Ai Zheng; 2004 Aug; 23(8):933-8. PubMed ID: 15301718
[TBL] [Abstract][Full Text] [Related]
19. [Clinical and Prognostic analysis of 43 Children with Mature B-cell Non-Hodgkin's Lymphoma/Acute Lymphoblastic Leukemia].
Guo J; Zhu YP; Gao J; Li Q; Jia CS; Zhou CY; Guo X
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):72-9. PubMed ID: 26913397
[TBL] [Abstract][Full Text] [Related]
20. BLyS levels in sera of patients with systemic lupus erythematosus: clinical and serological correlation.
Elbirt D; Asher I; Mahlab-Guri K; Bezalel-Rosenberg S; Edelstein V; Sthoeger Z
Isr Med Assoc J; 2014 Aug; 16(8):491-6. PubMed ID: 25269340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
